English

pfizer / English

Stories published in last 24 hours
  • Related stories in the last 90 days
  • Stories published in last 24 hours

Today News

03

Pfizer Unit Wins $107.5M Patent Verdict Against AstraZeneca

www.law360.com

A Delaware federal jury on Friday said that AstraZeneca Pharmaceuticals LP should pay $107.5 million in royalty damages for infringing a Pfizer-brand cancer treatment patent, although a final decision won't be issued until after a bench…

Friday, May 17

00

Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech

www.bostonglobe.com

The Cambridge biotech said Friday that the European Patent Office has upheld the validity of one of its key patents, a victory in an ongoing dispute with Pfizer and BioNTech over rival COVID-19 vaccines.

23

19

European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech

www.benzinga.com

Moderna wins a crucial legal battle at the European Patent Office against Pfizer and BioNTech over Covid-19 vaccine patents.

18

Moderna wins Covid jab patent dispute over Pfizer and BioNTech

www.ft.com

Decision is a boon for the mRNA-vaccine maker in its legal fight to recoup pandemic profits from rivals

06

Thursday, May 16

22

15

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game

www.benzinga.com

On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France, just ahead of this year’s “Choose…

10

Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report

www.benzinga.com

In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc has agreed to pay up to $250 million.

07

Pfizer offers up to $250mn to settle thousands of Zantac cancer lawsuits

www.ft.com

Agreement aims to resolve a big portion of litigation in Delaware over discontinued heartburn drug

Wednesday, May 15

16

Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades'

www.benzinga.com

On CNBC's “Halftime Report Final Trades,” Joshua Brown of Ritholtz Wealth Management said under $30, Pfizer Inc. (NYSE:PFE) is a gift.

15

01

SPECIAL JABS: Pfizer employees received a “separate and distinct” COVID-19 vaccine, according to leaked Pfizer email

www.naturalnews.com

(NaturalNews) It’s now evident that multiple experiments were conducted on the global population under the pretense of “vaccination.” A Pfizer whistleblower...

Pfizer just agreed to settle 10,000-plus Zantac cancer lawsuits – but it did it QUIETLY hoping nobody would notice

www.naturalnews.com

(NaturalNews) You probably missed it since barely anybody is reporting on it, but Pfizer, unbeknownst to the vast majority of America, just settled more than...

Monday, May 13

00

Pfizer unleashed wave of turbo cancers with its COVID jabs; now the corporation is declaring cancer “our new COVID” profit stream

www.naturalnews.com

(NaturalNews) Now that its Wuhan coronavirus (COVID-19) "vaccines" have had time to trigger turbo cancers in many of the victims who took them, pharmaceutical...

21

Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients

www.benzinga.com

Pfizer seeks to expands its reach with 'Pfizer for All,' offering direct-to-consumer medical services, including COVID treatments & telehealth.

18

Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector

www.benzinga.com

Pfizer and AstraZeneca invest over $1 billion in France's healthcare sector, bolstering R&D capabilities and job creation.

10

09

'Seems Low:' Elon Musk Questions Pfizer's $0 Tax Bill, But Did Tesla Pony Up To Uncle Sam?

www.benzinga.com

In December 2021, Musk paid a record-breaking $11 billion in federal income taxes, resulting from selling Tesla stock to finance his purchase of Twitter.